• 我が国のワクチン発祥の地、
    長崎から新たに始まるワクチン開発研究
About us

ワクチン研究開発拠点について

長崎大学感染症研究出島特区 ワクチン研究開発拠点は,「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」に採択された4つのシナジー拠点の一つです。長崎大学がこれまで研究してきた高病原性病原体や熱帯性病原体を対象としたワクチン開発を推進し,人類の脅威となる感染症に対するワクチン開発を目指します。
Careers

公募・求人情報

Publications

研究業績

Ngwe Tun, M. M., Raini, S. K., Fernando, L., Gunawardene, Y., Inoue, S., Takamatsu, Y., Urano, T., Muthugala, R., Hapugoda, M., & Morita, K. (2023). Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka. Journal of Infection and Public Health, 16(9), 1435–1442. https://doi.org/10.1016/j.jiph.2023.07.014
Nwe, K. M., Tun, M. M. N., Muthugala, R., Nabeshima, T., Balingit, J. C., Rajamanthri, L., Jayawardana, D., Attanayake, S., Inoue, S., Takamatsu, Y., Urano, T., & Morita, K. (2023). Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2–Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017. The American Journal of Tropical Medicine and Hygiene, 109(4), 917–925. https://doi.org/10.4269/ajtmh.22-0780
Ngwe Tun, M. M., Nwe, K. M., Balingit, J. C., Takamatsu, Y., Inoue, S., Pandey, B. D., Urano, T., Kohara, M., Tsukiyama-Kohara, K., & Morita, K. (2023). A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. Vaccines, 11(12), 1857. https://doi.org/10.3390/vaccines11121857
Furuse, Y. (2024). Characteristics of retracted research papers before and during the COVID-19 pandemic. Frontiers in Medicine, 10. https://www.frontiersin.org/articles/10.3389/fmed.2023.1288014
Yoshikawa, R., Kawakami, M., & Yasuda, J. (2023). The NSs protein of severe fever with thrombocytopenia syndrome virus differentially inhibits the type 1 interferon response among animal species. Journal of Biological Chemistry, 299(6), 104819. https://doi.org/10.1016/j.jbc.2023.104819
PAGE TOP